GEODE CAPITAL MANAGEMENT, LLC

Position in VSTM — Verastem, Inc.

CIK 1214717 BOSTON, MA

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,103,051

-$1,649,534 QoQ

Shares Held

1,717,557

+23.3% QoQ

Ownership

1.95%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. VSTM ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,103,051	1,717,557	+23.3%	Shares	Defined	2026-05-15
2025-12-31	$10,752,585	1,392,822	+11.9%	Shares	Defined	2026-02-09
2025-09-30	$10,989,649	1,244,581	+3.8%	Shares	Defined	2025-11-12
2025-06-30	$4,976,924	1,199,259	+24.9%	Shares	Defined	2025-08-08
2025-03-31	$5,790,391	960,264	+1.2%	Shares	Defined	2025-05-13
2024-12-31	$4,905,243	948,790	+6.5%	Shares	Defined	2025-02-12
2024-09-30	$2,662,890	890,599	+67.6%	Shares	Defined	2024-11-12
2024-06-30	$1,583,986	531,539	+113.5%	Shares	Defined	2024-08-09
2024-03-31	$2,937,633	248,952	+7.2%	Shares	Defined	2024-05-13
2023-12-31	$1,889,521	232,128	+5.6%	Shares	Defined	2024-02-13
2023-09-30	$1,787,908	219,915	+36.4%	Shares	Defined	2023-11-13
2023-06-30	$1,199,261	161,191	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.